From the Departments of Biology and
§ Biochemistry, Queen's University, Kingston,
Ontario K7L 3N6, Canada
Received for publication, September 28, 2000, and in revised form, April 4, 2001
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Pyruvate kinase (PK) from the cyanobacterium
Synechococcus PCC 6301 was purified 1,300-fold to
electrophoretic homogeneity and a final specific activity of 222 µmol
of pyruvate produced/min/mg of protein. The enzyme was shown to have a
pI of 5.7 and to exist as a 280-kDa homotetramer composed of 66-kDa
subunits. This PK appears to be immunologically related to
Bacillus PK and a green algal chloroplast PK, but not to
rabbit muscle PK, or vascular plant cytosolic and plastidic PKs. The
N-terminal amino acid sequence of the Synechococcus PK
exhibited maximal (67%) identity with the corresponding region of a
putative PK-A sequence deduced from the genome of the cyanobacterium,
Synechocystis PCC 6803. Synechococcus PK was
relatively heat-labile and displayed a broad pH optimum around pH 7.0. Its activity was not influenced by K+, but required high
concentrations of Mg2+, and was relatively nonspecific with
respect to the nucleoside diphosphate substrate. Potent allosteric
regulation by various effectors was observed (activators: hexose
monophosphates, ribose 5-phosphate, glycerol 3-phosphate, and AMP;
inhibitors: fructose 1,6-bisphosphate, inorganic phosphate, ATP, and
several Krebs' cycle intermediates). The enzyme exhibited marked
positive cooperativity for phosphoenolpyruvate, which was eliminated or
reduced by the presence of the allosteric activators. The results are
discussed in terms of the phylogeny and probable central role of PK in
the control of cyanobacterial glycolysis.
The capture of a photosynthetic prokaryote and its conversion into
an energy-producing chloroplast was one of the key events in the
evolution of the plant kingdom. Although plastid-bearing green algae
and vascular plants display remarkable diversity, they can all be
traced to a single successful endosymbiotic event between a
cyanobacterium-like ancestor and a eukaryotic phagotroph (1).
Cyanobacteria, also known as blue-green algae, are widely distributed
aquatic eubacteria in which photosynthetic CO2 fixation is
mediated by the reductive pentose phosphate pathway. These organisms make a substantial contribution to global CO2
assimilation, O2 recycling, and N2-fixation,
and are increasingly becoming important targets for biotechnology.
In nature, most cyanobacteria face a regular cycle of light and dark.
In order to meet the energy demands for maintenance and growth, they
must resort to heterotrophic dark energy generation. While
cyanobacterial oxygenic photosynthesis and its related metabolism have
been extensively characterized, our knowledge of dark carbon metabolism
and its control in cyanobacteria is comparatively sparse. In most
species, glycogen accumulated during the day serves as the predominant
metabolic fuel at night (2). Glucose residues derived from glycogen are
catabolized via the oxidative pentose-phosphate pathway, the lower
portion of glycolysis, and an incomplete Krebs' cycle, leading to the
production of ATP and C-skeletons needed as anabolic precursors.
However, despite the ecological, economic, and evolutionary importance
of cyanobacteria, nothing is known about the properties of many
potential control enzymes of their carbohydrate catabolizing pathways.
One such enzyme is pyruvate kinase
(PK),1 considered to be a key
regulatory enzyme of the glycolytic pathway in all the phyla.
Pyruvate kinase catalyzes the irreversible substrate level
phosphorylation of ADP at the expense of PEP, producing pyruvate and
ATP. It has been fully purified and extensively characterized from a
wide variety of animals, plants, yeast, and non-photosynthetic bacteria
where it generally exists as a homotetramer with a subunit molecular
mass of 55-60 kDa. Both allosteric controls and reversible protein
kinase-mediated phosphorylation may be used to coordinate the activity
of animal or yeast PKs with the energy and carbohydrate demands of the
cell (3-5). Similarly, bacterial (6, 7), green algal (8), and vascular
plant (9, 10) PKs demonstrate tight allosteric control by a variety of
metabolite effectors.
Animal and vascular plant PKs are expressed as tissue-specific isozymes
that display catalytic and regulatory properties reflecting the
differing metabolic requirements of the respective tissues (3-5, 10).
PK isozymes, however, are not restricted to eukaryotes. For example,
two types of allosteric PKs occur in Escherichia coli and
Salmonella typhimurium (6, 7). In E. coli, PK-F is inducible and activated by Fru-1,6-P2, whereas the PK-A
is constitutive and activated by AMP and ribose-5-P (6). The latter may
play an essential role to produce ATP under anaerobic conditions.
In all eukaryotes PK is cytosolic, but vascular plant and green algal
PK exists as both cytosolic and plastid isozymes (PKc and
PKp, respectively) that differ in their respective
physical, immunological, and kinetic/regulatory characteristics
(8-14). Although nuclear-encoded, the plastid isozymes of most
glycolytic enzymes are generally believed to have arisen from the
original cyanobacterial endosymbiont, whereas the cytosolic isozymes
appear to be orthologous to their animal or yeast homologs and to have been inherited from proteobacteria (15). Based upon phylogenetic analyses of the primary structure of plant, animal, and
non-photosynthetic bacterial PKs, Hattori and co-workers (12) concluded
that plant PKps are more similar to eubacterial homologs,
than they are to eukaryotic PK. Similarly, immunological studies
implied structural relatedness of a green algal PKp to
Bacillus stearothermophilus PK, but not vascular plant or
mammalian PKs (13).
Several reports have documented the PK activity of clarified
cyanobacterial extracts (as cited in Ref. 2), and a genome sequencing
project (16) has indicated the presence of two PK-encoding genes in the
cyanobacterium Synechocystis PCC 6803. However, no information is available on the enzymatic properties of any
cyanobacterial PK. In this study, we describe the purification to
homogeneity of a cyanobacterial PK, and report the structural and
regulatory properties of the purified enzyme. By analyzing PK from
Synechococcus PCC 6301, we hope to better understand the
control mechanisms governing primary carbon metabolism in
cyanobacteria, and to gain insights into the structure, function, and
evolutionary significance of cyanobacterial PK.
Cell Culture--
Synechococcus PCC 6301 (also known
as Synechococcus leopoliensis and Anacystis
nidulans R2 (17)) was obtained from the University of Toronto
Culture Collection as UTCC number 102. Cells were cultured in
chemostats (18) at 20 °C under a light intensity of 70 µE·m Enzyme and Protein Assays--
All solutions were prepared using
Milli-Q processed water. The PK reaction was coupled to the lactate
dehydrogenase reaction and assayed at 24 °C by monitoring NADH
oxidation at 340 nm, in a final volume of 1 ml. Unless otherwise
indicated, assay conditions for PK were 50 mM imidazole-HCl
(pH 7.0), 2.5 mM PEP, 1 mM ADP, 30 mM MgCl2, 0.15 mM NADH, and 2 units/ml desalted rabbit muscle lactate dehydrogenase. The
mono(cyclohexylammonium) salts of PEP and ADP were employed. Assays
were linear with respect to time and concentration of enzyme assayed.
One unit of PK activity is defined as the amount of enzyme resulting in
the utilization of 1 µmol of PEP/min. Protein concentrations
were determined using a Coomassie Blue G-250 dye-binding method (20)
with bovine Kinetic Studies--
Kinetic studies were performed using a
Dynatech MR-5000 Microplate reader and a final volume of 0.2 ml for the
PK reaction mixture. Apparent Vmax
(Vmax,app), Km, or
S0.5, and Hill coefficient values for substrates
and cofactors were calculated from the Hill equation fitted to a
nonlinear least-squares regression computer kinetics program (21).
I50 and Ka values
(concentrations of inhibitor and activator producing 50% inhibition
and activation of PK activity, respectively) were calculated using the
aforementioned computer program. Stock solutions of metabolites were
adjusted to pH 7.0, and the concentration of nucleotides was verified
spectrophotometrically using published extinction coefficients.
The influence of pH on Vmax,app was determined
using a mixture of 25 mM MES and 25 mM BIS-TRIS
propane as the assay buffer, titrated to the desired pH with either KOH
or HCl. The pH of kinetic assays was determined immediately following
completion of each set of assays. Vmax,app
values were estimated by fitting PEP saturation kinetic data to the
Hill equation as described above. Estimation of pKa
values for the enzyme-PEP complex was made from a plot of log
Vmax,app versus pH as described by
Dixon and Webb (22).
Concentrations of free Mg2+ and Mn2+ were
calculated based upon their respective binding to
organophosphates, nucleotides, organic acids, Pi, and
Cl Purification of PK--
All procedures were carried out at
4 °C, unless otherwise noted. All buffers contained 1 mM
dithiothreitol, 5 mM MgCl2, and 1 mM EDTA in addition to the following: Buffer A contained 50 mM imidazole-HCl (pH 7.2), 1 mM EGTA, 20 mM NaF, 25 mM KCl, 15% (v/v) glycerol, and
0.1% (v/v) Triton X-100. Buffer B contained 50 mM
Hepes-NaOH (pH 7.1) and 15% (saturation)
(NH4)2SO4. Buffer C contained 50 mM Hepes-NaOH (pH 7.1) and 10% (v/v) ethylene glycol. Buffer D contained 20 mM imidazole-HCl (pH 7.1) and 20%
(v/v) glycerol. Buffer E contained 10 mM NaPi
(pH 7.1) and 20% (v/v) glycerol.
Quick-frozen cells (100 g) were thawed, brought to 1 mM
dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, and 10 mM thiourea, and lysed by two passages through a French
press at 18,000 psi (124 MPa). The lysate was clarified by
centrifugation at 35,000 × g for 20 min. The clarified
extract was adjusted to 15% (saturation) (NH4)2SO4 by the addition of finely
ground (NH4)2SO4, stirred for 20 min, and centrifuged as above. The supernatant was gently stirred for
30 min with 130 ml of Butyl-Sepharose 4 Fast Flow (Amersham Pharmacia
Biotech) that had been pre-equilibrated with buffer B. The slurry was
poured into a column (3.2 × 17 cm), connected to an ÄKTA
FPLC system (Amersham Pharmacia Biotech), and washed overnight at 1 ml/min with 800 ml of buffer B. Adsorbed proteins were eluted at 3 ml/min using a 520-ml linear gradient (100-0% buffer B simultaneous
with 0-100% buffer C; fraction size = 20 ml). Pooled peak PK
activity fractions were concentrated to 10.5 ml with an Amicon YM-100
ultrafilter, adjusted to 10 µg/ml chymostatin and 2 mM
dithiothreitol, and dialyzed overnight against 2 liters of buffer C.
The sample was centrifuged as above, diluted to about 15 mg of
protein/ml in buffer D, and loaded at 1 ml/min onto a column (1.1 × 9.5 cm) of Fractogel EMD DEAE-650 (S) (Merck) that had been
connected to the FPLC system and pre-equilibrated with buffer D. The
column was washed with buffer D until the A280
decreased to baseline. PK activity was eluted following application of
a linear 0 to 500 mM KCl gradient (135 ml) in buffer D
(fraction size = 5 ml). Peak activity fractions were concentrated
to 1 ml as above, and desalted at 1 ml/min on a 5-ml Hi-Trap Sephadex G-50 column (Amersham Pharmacia Biotech) pre-equilibrated with buffer E.
Blue Dextran-agarose (BDA) affinity chromatography was conducted at
24 °C. The desalted sample was immediately loaded at 0.5 ml/min onto
a column (1 × 6.5 cm) of BDA (Sigma) that had been pre-equilibrated with buffer E. The column was washed with 30 ml of
buffer E, and then with 30 ml of buffer E containing 2 mM ADP (fraction size = 2.5 ml). PK activity was eluted in a broad peak (approximately 70 ml) by the application of buffer E containing 2 mM ADP and 1 mM PEP. Immediately following the
collection of 4 consecutive fractions containing PK activity, they were
pooled, passed through a 0.45-µm syringe filter, and injected using a 10-ml Superloop at 0.5 ml/min onto a Mono-Q HR 5/5 column (Amersham Pharmacia Biotech) pre-equilibrated with buffer E. This process was
repeated until all PK activity eluting from the BDA column had been
loaded onto the Mono-Q column.
PK activity was eluted following application of a linear 10 to 200 mM NaPi gradient (35 ml) in buffer E (fraction
size = 0.75 ml). Peak activity fractions were pooled, concentrated
to 1 ml using an Amicon PM-30 ultrafilter, divided into 20-µl
aliquots, frozen in liquid N2, and stored at Antibody Production and Immunotitration of PK
Activity--
Production of rabbit anti-(Synechococcus PK)
immune serum (using 180 µg of purified PK) and immunoremoval of PK
activity was performed as previously described (9). Affinity-purified
rabbit anti-(castor (Ricinus communis) seed PKc,
castor seed PKp, or green algal (Selenastrum
minutum) PKp) IgGs and goat anti-(rabbit muscle PK)
IgG were obtained as already reported (11, 13, 14).
Electrophoresis and Immunoblotting--
SDS-PAGE and subunit
Mr determination was performed as previously
described (9). Nondenaturing IEF-PAGE was performed over the pH range 3 to 10 using precast Bio-Rad mini-gels according to the manufacturers
instructions. The enzymes pI was determined by comparing the mobility
of Synechococcus PK with that of six protein standards
having pI values ranging from 4.55 to 9.3.
Immunoblotting was performed after electroblotting protein from SDS
mini-gels to poly(vinylidene difluoride) membranes as previously
described (9, 11). Immunological specificities were confirmed by
performing immunoblots in which rabbit preimmune serum was substituted
for the anti-(Synechococcus PK) immune serum.
N-terminal Sequencing--
Sequencing of purified PK (20 µg)
was performed by automated Edman degradation at the Harvard
Microchemistry Facility. Similarity searches were conducted with the
BLAST program available on the National Center for Biotechnology
Information World Wide Web site (24) and the GenBankTM data base.
Purification, and Physical, Immunological, and Structural
Characterization
Purification of PK from Synechococcus PCC 6301--
As shown in
Table I, PK was purified 1,300-fold to a
final specific activity of 222 units/mg and an overall recovery of
31%. A single peak of PK activity was obtained following all
chromatographic steps. The marked hydrophobicity of the enzyme was
exploited during Butyl-Sepharose FPLC of the clarified extract that
resulted in a 19-fold purification (Table I). Mono-Q FPLC led to a
chromatographically homogeneous preparation since the enzyme eluted
from this column as a single symmetrical PK activity and
A280 absorbing peak (results not shown).
Physical Properties--
The purified enzyme was relatively
heat-labile, retaining 100, 79, 58, and 0% of its activity following a
3-min incubation at 40, 50, 55, and 60 °C, respectively.
Denaturation, followed by SDS-PAGE of the final preparation, resolved a
single Coomassie Blue staining 66-kDa polypeptide (Fig.
1A, lanes 2 and 3),
that cross-reacted strongly with the anti-(Synechococcus PK)
immune serum (Fig. 1B, lane 2). Nondenaturing
IEF-PAGE resolved a single Coomassie Blue staining polypeptide with a
pI value of 5.7 (Fig. 1D). The native
Mr was determined to be 280 ± 30 kDa
(mean ± S.E., n = 3) as estimated by gel
filtration FPLC on a calibrated Superose 6 column. Thus, the native PK
appears to be homotetrameric.
Immunological Properties--
Increasing amounts of rabbit
anti-(Synechococcus PK) immune serum immunoprecipitated
100% of the activity of the purified PK. Complete immunoremoval of
activity occurred at about 10 µl of immune serum per unit of PK
activity. Preimmune serum had no effect on PK activity. The
anti-(Synechococcus PK) immune serum could readily detect 10 pg of denatured Synechococcus PK (Fig. 1B,
lane 2). Immunoblotting of 10 ng of protein from a clarified Synechococcus extract demonstrated monospecificity of the
anti-(Synechococcus PK) immune serum for the 66-kDa PK
subunit (Fig. 1B, lane 1). No cross-reaction was
observed when immunoblots of 250 ng of the following homogeneous PK
preparations were probed with this anti-(Synechococcus PK)
immune serum: rabbit muscle PK, and green algal (S. minutum), or vascular plant (castor and rapeseed) PKc
and PKp. Similarly no cross-reaction was observed when an
immunoblot of 250 ng of the purified Synechococcus PK was
probed with anti-(rabbit muscle PK or rapeseed PKc or
castor seed PKp) IgGs. However, a cross-reaction was
observed between the anti-(Synechococcus PK) immune serum and B. stearothermophilus PK (Fig. 1B, lane
3), and between the anti-(green algal PKp) IgG and
B. stearothermophilus and Synechococcus PKs (Fig.
1C, lanes 1 and 2).
N-terminal Sequence Comparison--
The N-terminal
15-residue amino acid sequence of the 66-kDa subunit of
Synechococcus PK was determined and compared with its counterpart in other PKs (Fig. 2). The
sequence best aligned with the corresponding region deduced from the
nucleotide sequence of a putative PK-A gene from the cyanobacterium
Synechocystis PCC 6803 (16). The next closest resemblance
was with the N terminus of Synechocystis PK-F, followed by
other bacterial PKs.
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2 s
1 in modified Allen's medium
(19) from which Na2CO3,
Na2SiO3·9H2O, and Fe-citrate were
omitted, and to which 50 mM Hepes-NaOH (pH 8.5), 10 µM EDTA, 857 µM citric acid, and 65 µM FeSO4 were added. Chemostats were bubbled
with CO2-enriched air (5%). Cells were harvested from the
chemostat outflow every 3 days by centrifugation at 6,400 × g. Pellets were resuspended in 2 volumes of buffer A (see
below), frozen in liquid N2 and stored at
80 °C.
-globulin as the protein standard.
ions using a computer program that automatically
corrects for temperature, pH, and ionic strength (23). PK activity was
independent of free Mg2+ concentrations in the range of 23 to 40 mM. For studies of the enzymes substrate saturation
kinetics and response to metabolite effectors, the stock solutions of
nucleotides, PEP, organic acids, and Pi were made equimolar
with MgCl2, thus maintaining free Mg2+
concentrations in excess of 23 mM. Metabolite or substrate
concentrations stated in the text refer to their total concentration in
the assay medium unless otherwise noted.
80 °C
until used. Purified PK was stable for at least 9 months when stored
frozen. The native Mr was estimated by gel
filtration FPLC on a calibrated Superose 6 HR 10/30 column as
previously described (9).
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Purification of PK from 100 g of chemostat-cultured Synechococcus
PCC 6301
View larger version (17K):
[in a new window]
Fig. 1.
SDS-PAGE, immunoblot, and IEF-PAGE analyses
of PK from Synechococcus PCC 6301. A,
SDS-PAGE (7.5% (w/v) separating gel) of purified
Synechococcus PK. Lane 1 contains 2 µg of
various protein standards. Lanes 2 and 3 contain
1 and 4 µg, respectively, of the final preparation. Protein staining
was performed with Coomassie Blue R-250. B and C,
immunoblot analyses were performed using anti-(Synechococcus
PK)-immune serum (B) or anti-(green algal (Selenastrum
minutum) PKp)-IgG (13) (C). Antigenic
polypeptides were visualized using an alkaline phosphatase-tagged
secondary antibody and a chromogenic substrate as previously described
(9, 11). Phosphatase staining was for 5 to 10 min at 25 °C.
B. Lane 1 contains 10 ng of protein from a
clarified extract prepared from Synechococcus PCC 6301 cells. Lane 2 contains 10 pg of purified
Synechococcus PK. Lane 3 contains 100 ng of
B. stearothermophilus PK. C. Lane 1 contains 25 ng B. stearothermophilus PK. Lane 2 contains 50 ng of Synechococcus PK. Lane 3 contains 25 ng of a purified green algal (S. minutum)
PKp, previously demonstrated to exist as an unusual 210-kDa
monomer in its native state (13). D, nondenaturing IEF-PAGE
of 5 µg of purified Synechococcus PK.
View larger version (19K):
[in a new window]
Fig. 2.
Comparison of the N-terminal amino acid
sequence of Synechococcus PCC 6301 PK and other
PKs. Sequences of PKs except that of Synechococcus PK
(Syn PCC 6301) were taken from the GenBankTM data base.
Origins of PK are: SYN PK-A and SYN PK-F, Synechocystis PCC
6803 (GenBankTM accession numbers P73534 and Q55863); BS,
B. stearothermophilus (Q02499); EC PK-A, E. coli
PK-A (P14178); EC PK-F, E. coli PK-F (P21599); HS-M2, human
muscle PK (P14786); TOB PKp, tobacco plastid PK (Q40546);
and SOY PKc, soybean cytosolic PK (Q42806).
Hyphens denote amino acid residues that are identical to
that of Synechococcus PK. Underlined letters
indicate positions with the conservative substitutions Glu, Asp, Asn,
and Gln; Ile, Leu, Met, and Val; Phe, Tyr, and Trp; Ala, Gly, and Pro;
Ser and Thr; and Arg and Lys using the standard one-letter
abbreviations. Numbers in parentheses indicate
the position of the right side amino acid residues from the N
terminus.
Kinetic Properties
Effect of pH--
The influence of pH on the
Vmax,app of purified Synechococcus PK
was determined over the pH range of 5.2 to 8.9. The enzyme exhibited a
broad pH-Vmax,app profile with a maximum
occurring at approximately pH 7.0 (Fig.
3). The results indicate that the deprotonation and protonation of groups having pKa
values of about 6.0 and 7.8, respectively, are needed for catalytic
activity. It should be noted that these pKa values
must be interpreted with caution as they may not accurately reflect the
pKa of a specific ionizable group (22).
|
At pH 7.0 the enzyme showed equivalent activity in 50 mM imidazole, 50 mM Hepes, or a mixture of 25 mM MES and 25 mM Bis-Tris propane, whereas about 10% lower activity was obtained with 50 mM MOPS as the assay buffer. Subsequent kinetic studies were routinely conducted using 50 mM imidazole buffer at pH 7.0 and 7.5 which, respectively, correspond to the estimated intracellular pH of Synechococcus PCC 6301 in the dark and light (25).
Cofactor Requirements and Substrate Saturation Kinetics-- Unlike most known PKs, the activity of Synechococcus PK was independent of a monovalent cation such as K+, Na+, or NH4+. Enzymatic activity was unaffected by KCl concentrations in the range of 0 to 100 mM. To eliminate the presence of 0.3 mM Na+ during the PK activity determination (due to the addition of 0.15 mM Na2-NADH to the standard coupled reaction mixture), a fixed timed assay was utilized in which NADH and lactate dehydrogenase were initially omitted. The reaction was terminated after 3 min (by boiling for 1 min) and the amount of pyruvate produced quantified spectrophotometrically at 340 nm, 10 min following the addition of 0.15 mM NADH and 2.5 units/ml of rabbit muscle lactate dehydrogenase. While Synechococcus PK activity was unaffected by the absence of added monovalent cations, the K+-dependent rabbit muscle PK showed no activity when parallel continuous or fixed timed PK assays were conducted in the absence of 30 mM KCl.
Tables II and III summarize the Vmax,app and Km or S0.5 values obtained for PEP, ADP, and metal cation cofactors at pH 7.0 and 7.5. As demonstrated for other PKs, the activity of the cyanobacterial enzyme showed an absolute dependence for a divalent metal cation with Mg2+ or Mn2+ fulfilling this requirement. Mg2+ and particularly PEP exhibited sigmoidal saturation curves, whereas Mn2+ and ADP followed Michaelis-Menten saturation kinetics (Tables II and III; Fig. 4). The Vmax,app at pH 7.0 or 7.5 was about 20% lower when Mn2+ was substituted for Mg2+. At both pH values the apparent S0.5 value for free Mg2+ was slightly lower than the corresponding apparent Km value for free Mn2+. Thus, catalytic efficiencies obtained with Mg2+ were greater than those obtained with Mn2+ (Table II), indicating that Mg2+ is the preferred divalent metal cation cofactor.
|
|
|
Although increasing the assay pH from 7.0 to 7.5 exerted a negligible influence on the apparent Km(ADP) (Table III), it provoked an approximate 15% reduction in the apparent S0.5(PEP) value without markedly altering the Hill coefficient for PEP saturation (Table II). The addition of 5% (w/v) PEG 8,000 or 20% (v/v) glycerol to the reaction mixture did not alter PEP or ADP saturation kinetics of the enzyme.
This PK appears to be relatively nonspecific with respect to the nucleoside diphosphate substrate (Table III). Although Vmax,app values obtained with saturating UDP, CDP, and GDP were either equivalent or similar to that obtained with ADP, the apparent Km values for the alternative nucleoside substrates were up to 15-fold greater than the apparent Km(ADP) value. Consequently, the catalytic efficiency achieved with ADP was at least 7-fold greater than the value obtained with any other nucleoside substrate (Table III), indicating that ADP is the preferred substrate for the enzyme. At concentrations greater than 5 mM, ADP became slightly inhibitory (10 mM ADP yielded about 85% of the activity achieved at 1 mM ADP). This inhibition is likely due to the interaction of PK with MgADP, as at 10 mM total ADP the concentrations of free ADP, HADP, MgHADP, and MgADP in the PK reaction mixture were estimated (22) to be 0.25, 0.09, 0.11, and 9.55 mM, respectively.
Metabolite Effects-- A wide variety of compounds were tested as possible PK effectors at pH 7.0 and 7.5 with subsaturating concentrations of PEP and ADP (0.6 and 0.15 mM, respectively). The following compounds had little or no influence (± 15% of control velocity) on PK activity at either pH value: sucrose, mannose, Glc, Fru, dihydroxyacetone phosphate, shikimate, ADP-glucose, alanine, lysine, glycine, glutamine, glutamate, asparagine, aspartate, glycolate 2-phosphate, 2-phosphate glycerate, 3-phosphate glycerate, isocitrate, succinate, and NH4Cl (all 5 mM); phenylalanine, tyrosine, tryptophan, and acetyl-CoA (0.5 mM each); and rutin, quercetin, and Fru-2,6-P2 (0.1 mM each). Table IV lists those compounds that significantly influenced the activity of the purified enzyme. This PK was generally more responsive to the various effectors at pH 7.0 than at pH 7.5 (Table IV).
|
Activators-- Significant activators were the hexose phosphates, ribose 5-phosphate, glycerol 3-phosphate, and relatively low concentrations of AMP (Table IV). Synergistic or additive effects of activators at pH 7.0 were not observed, suggesting that they may all interact at a common site. The extent of activation was inversely proportional to PEP concentration (Tables IV and V; Fig. 4). This arises from the fact that although Glc-6-P, ribose 5-phosphate, or glycerol-3-P only slightly increased Vmax,app, they decreased the S0.5(PEP) value by 4-7-fold, while eliminating or significantly reducing the positive cooperativity with respect to PEP (Table II; Fig. 4). Ribose 5-phosphate also functioned as an activator by relieving inhibition by Pi, ATP, citrate, and Fru-1,6-P2. The presence of 0.12 mM ribose 5-phosphate increased I50 values for these inhibitors from 50 to 350% (Table V). In addition, the fold activation by saturating ribose 5-phosphate was increased from about 5-fold to almost 11-fold in the presence of 2.5 mM Pi (Table V). At 0.3 mM PEP, the Ka values for Glc-6-P and ribose 5-phosphate were extremely low, in the range of 1 to 3 µM, whereas the Ka(glycerol 3-phosphate) value was over an order of magnitude larger (Table V). The addition of 0.25 mM ribose 5-phosphate did not influence the apparent Km for ADP.
|
Inhibitors--
The most effective inhibitors were
Fru-1,6-P2, malate, 2-oxoglutarate, citrate, ATP, and
Pi (Table IV). Inhibition of PK activity by these compounds
was not an artifact due to Mg2+ chelation, since the
concentration of free Mg2+ ions was always maintained at
saturating levels (e.g. >23 mM; see
"Experimental Procedures"). At concentrations in excess of 3.5 mM, AMP also functioned as an inhibitor (Table IV).
Additive inhibition was observed when the following inhibitors were
tested in pairs: malate, 2-oxoglutarate, citrate,
Fru-1,6-P2, and Pi (5 mM each)
(results not shown). This suggests that they may all interact at
distinct sites on the enzyme. However, additive inhibition was not
observed with 1 mM ATP, 5 mM Pi, or
5 mM AMP indicating that they may compete for a common
site. At pH 7.0, Fru-1,6-P2, citrate, ATP, and
Pi functioned as inhibitors by increasing the S0,5 for PEP (Table II; Fig. 4), and
Ka for Glc-6-P and ribose 5-phosphate (Table V).
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
This study was undertaken with the goals of purifying a cyanobacterial PK for the first time, and comparing it structurally and kinetically with other PKs. In non-photosynthetic eubacteria such as E. coli and S. typhimurium two PK isozymes may coexist under a wide range of nutritional states (6, 7). In contrast, only one type of allosteric PK has been found in other microorganisms such as B. stearothermophilus and Pseudomonas citronellis (26, 27). That cyanobacteria may contain PK isozymes was recently deduced via genomic sequencing of Synechocystis PCC 6803 in which two putative PK-encoding genes have been identified (16). However, during the isolation of PK from Synechococcus PCC 6301 only a single peak of activity was resolved during all chromatographic steps, suggesting that a single PK isoform is expressed in this cyanobacteria under the culture conditions that were employed. The Synechococcus PK was purified to a specific activity (>200 units/mg; Table I) comparable to that of homogeneous PKs from other sources (7, 9, 11, 13, 14, 26, 27). Homogeneity of the final preparation was confirmed by SDS- and IEF-PAGE which each generated single protein-staining polypeptides (Fig. 1, A and D). Similar to PK from most other prokaryotic and eukaryotic sources, the purified enzyme was shown to have a pI value of about 5.7 and to exist as a 280-kDa homotetramer composed of 66-kDa subunits.
The structural relationship between Synechococcus PCC 6301 PK and other prokaryotic and eukaryotic PKs was investigated. Immunological comparison of PKs from various origins showed no cross-reaction between the anti-(Synechococcus PK) immune serum and rabbit PK or vascular plant PKc and PKp, nor between the Synechococcus PK and anti-(rabbit muscle PK or vascular plant PKc and PKp)-IgGs. However, a cross-reaction was observed between: (i) anti-(Synechococcus PK) immune serum and B. stearothermophilus PK (Fig. 1B), and (ii) anti-(green algal PKp) IgG and Synechococcus or B. stearothermophilus PKs (Fig. 1C). The immunological analysis suggests that there is conservation of a few epitopes between Synechococcus PK and green algal PKp, and B. stearothermophilus PK. However, cyanogen bromide fragmentation patterns of purified Synechococcus PK, B. stearothermophilus PK, green algal PKp, rabbit muscle PK, and vascular plant PKc were distinct.2 CNBr peptide maps depend on the position and number of methionine residues in the protein. Therefore, the location of methionine residues in the Synechococcus PK is quite different from that of the other prokaryotic and eukaryotic PKs that were examined.
The N-terminal sequence of the Synechococcus 66-kDa PK subunit showed the best alignment (67% identity) with the corresponding region deduced from the nucleotide sequence of the PK-A gene from the cyanobacterium Synechocystis PCC 6803 (Fig. 2). The next closest resemblance was with the N termini deduced for Synechocystis PK-F and E. coli PK-A. Although the N terminus of Synechococcus PK appears to be conserved to varying degrees in all PKs examined to date (Fig. 2), the Synechococcus enzyme lacked the N-terminal domain found in mammalian PK and vascular plant PKc and PKp, as do the Synechocystis, E. coli, and B. stearothermophilus enzymes. This may be a characteristic of bacterial PKs. A comparison of the positional identities of Synechocystis PK-A with PK-F (Fig. 2) shows that they have about the same similarity relative to each other (45%) as they do to B. stearothermophilus PK. The sequence similarity rises to 62 to 65% if conservative amino acid substitutions are included. Surprisingly, plant PKp does not cluster together with either PK-A or PK-F from Synechocystis. It has been suggested that high evolutionary rates of plant plastid-localized enzymes mask their true phylogenetic relationship (28). Overall the results imply that the Synechococcus PK examined here is related to PKs from cluster A, but is only distantly related to animal PKs, green algal or vascular plant PKc, and vascular plant PKp.
The purified Synechococcus PK was inactivated by heating at 60 °C for 3 min, as is the heat labile PKp, but not PKc from vascular plants and green algae (9, 11, 14, 29, 30). Similarly, PK-A but not PK-F, from the bacterium S. typhimurium is heat labile (7).
In common with many PKs, the Synechococcus enzyme exhibited a broad pH optimum of about pH 7.0. Thus, this PK may become more active in the dark, as cessation of photosynthetic electron transport with the light to dark transition causes the intracellular pH of Synechococcus PCC 6301 to decrease from about pH 7.5 to 7.0 (25). Although sensitivity of the enzyme to metabolite effectors was slightly dampened at the higher pH value (Table IV), efficiency of substrates utilization was comparable at both pH 7.0 and 7.5 (Tables II and III). As with all known PKs, the Synechococcus enzyme required a divalent metal cation cofactor, with Mg2+ or Mn2+ satisfying this requirement. However, a rather unusual feature was the enzymes apparent lack of dependence on a monovalent cation such as K+. Although rare, this has been reported for PK from several eubacterial and archaeal sources (27, 28, 31), as well as for a least one eukaryotic PK (from the amitochondrial protist Trichomona vaginalis) (32). In contrast, the vast majority of eukaryotic PKs, including green algal and vascular plant PKc and PKp (8, 9, 29, 30), require both a monovalent and divalent metal cation cofactor. Although ADP was the preferred cosubstrate, the cyanobacterial PK showed a broad specificity for nucleoside diphosphates (Table III), resembling other bacterial PKs.
In the darkened, aerobic state, cyanobacteria have been shown to catabolize glycogen-derived hexose monophosphates primarily through the oxidative pentose-phosphate pathway and an incomplete Krebs' cycle (2). It is interesting that the Synechococcus PK was potently activated by key intermediates of glycogen breakdown and the oxidative pentose-phosphate pathway, Glc-6-P and ribose 5-phosphate, respectively (Tables II, IV, and V; Fig. 4). In each case, the net effect of activation would be to accelerate the conversion of glyceraldehyde-3-P to pyruvate with concomitant ATP production. The activators function by greatly increasing the activity of the enzyme at low, physiologically relevant, PEP concentrations (Table II, Fig. 4), and reducing its sensitivity to the various inhibitors (Table V). In the absence of activators, PEP shows strong positive cooperativity with the enzyme and a relatively high S0.5 and thus, PEP functions as a homotropic activator of the enzyme. In the presence of appropriate activators the positive cooperativity is abolished or greatly reduced, and the S0.5 may be lowered by almost 10-fold (Table II, Fig. 4). The activation by ribose 5-phosphate specifically affects the S0.5 for PEP, as no influence of this activator on ADP saturation kinetics was observed. Likewise, B. stearothermophilus and E. coli PK-A are activated by AMP, ribose 5-phosphate, or hexose phosphates, but not by Fru-1,6-P2 (6, 26). Activation of Synechococcus PK by AMP and ribose 5-phosphate (Tables II, IV, and V; Fig. 4) is consistent with its classification as a PK-A. Similar to ribose 5-phosphate-activated PK from E. coli and other bacterial sources, the enzyme from Synechococcus PCC 6301 was potently inhibited by Pi (Tables IV and V). However, an increase in the intracellular pool of Glc-6-P and ribose 5-phosphate may overcome inhibition by Pi (Table V). Pi is believed to contribute to the control of glycolytic flux in Streptococcus mutans (33). Further research is required to clarify the role of Pi in the control of cyanobacterial glycolysis. Inhibition by Krebs' cycle intermediates such as malate, 2-oxoglutarate, and citrate has been documented for a variety of PKs (8-10, 29) and provides a mechanism for respiratory control of this enzyme. ATP inhibition of PK is anticipated, as this compound is a product. Although low AMP concentrations stimulated Synechococcus PK activity, at higher, non-physiological concentrations, AMP functioned as an inhibitor (Table IV), likely by binding to the ATP inhibition site. The energy charge of Synechococcus PCC 6301 shows a marked transient reduction immediately following the light-dark transition (34), or when darkened aerobic cells are subjected to anoxia stress (35). Both perturbations should serve to enhance Synechococcus PK activity in vivo.
In conclusion, our results demonstrate that the activity of PK from
Synechococcus PCC 6301 is modulated mainly by energy charge, feedforward activation by intermediates of glucan polymer degradation (hexose monophosphates), and oxidative pentose-phosphate pathway (ribose 5-phosphate), and feedback inhibition by several Krebs' cycle
intermediates. These observations strongly suggest that PK plays a
significant role in the control of carbohydrate catabolism in
cyanobacteria. Immunological evidence revealed that PK from Synechococcus PCC 6301 may be phylogenetically related to
Bacillus PK and a green algal PKp. However, the
proposed cyanobacterial origin of green algal and vascular plant
PKps (12) is difficult to reconcile with the observation
that the activity of all plant or green algal PKps examined
to date demonstrates hyperbolic PEP saturation kinetics and an absolute
dependence for a monovalent cation cofactor (e.g.
K+) (8, 10, 29, 30). This contrasts with the sigmoidal PEP
saturation kinetics and lack of monovalent cation dependence that was
observed for the enzyme isolated from Synechococcus PCC 6301. Further research on cyanobacterial and plant/algal PKs may help
to clarify the origin of plastid-localized PKs.
![]() |
ACKNOWLEDGEMENTS |
---|
We are indebted to Dr. David Turpin for providing facilities for the chemostat culture of Synechococcus PCC 6301. We are also grateful to Drs. Steve Brooks, John Coleman, George Espie, Tom Nowak, Florencio Podestá, and Jean Rivoal for enlightening discussions.
![]() |
FOOTNOTES |
---|
* This work was supported by research and equipment grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) (to W. C. P.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Biology, Queen's University, Kingston, Ontario K7L 3N6, Canada. Tel.: 613-533-6150; Fax: 613-533-6617; E-mail: plaxton@biology.queensu.ca.
Published, JBC Papers in Press, April 9, 2001, DOI 10.1074/jbc.M008878200
2 J. Waller and W. C. Plaxton, unpublished data.
![]() |
ABBREVIATIONS |
---|
The abbreviations used are: PK, pyruvate kinase (EC 2.7.1.40); Fru, fructose; Glc, glucose; PAGE, polyacylamide gel electrophoresis; PEP, phosphoenolpyruvate; PK-A, AMP-activated pyruvate kinase; PK-F, fructose-1,6-bisphosphate-activated pyruvate kinase; PKc and PKp, cytosolic and plastidic pyruvate kinase isozymes, respectively; Vmax, app, apparent Vmax; MES, 4-morpholineethanesulfonic acid; MOPS, 4-morpholinepropanesulfonic acid; BIS-TRIS, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol; FPLC, fast protein liquid chromatography.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. | Douglas, S. E. (1998) Curr. Opin. Gen. Dev. 8, 655-661[CrossRef][Medline] [Order article via Infotrieve] |
2. | Stal, L. J., and Moezelaar, R. (1997) FEMS Microbiol. Rev. 21, 179-211[CrossRef] |
3. | Yamada, K., and Noguchi, T. (1999) Biochem. J. 337, 1-11[CrossRef][Medline] [Order article via Infotrieve] |
4. | Mattevi, A., Bolognesi, M., and Valentini, G. (1996) FEBS Lett. 389, 15-19[CrossRef][Medline] [Order article via Infotrieve] |
5. | Muirhead, H. (1999) Biochem. Soc. Trans. 18, 193-196 |
6. | Malcovati, M., and Valentini, G. (1982) Methods Enzymol. 90, 170-179[Medline] [Order article via Infotrieve] |
7. | Garcia-Olalla, C., and Garrido-Petierra, A. (1987) Biochem. J. 241, 573-581[Medline] [Order article via Infotrieve] |
8. | Lin, M., Turpin, D. H., and Plaxton, W. C. (1989) Arch. Biochem. Biophys. 269, 228-238[Medline] [Order article via Infotrieve] |
9. |
Smith, C. R.,
Knowles, V. L.,
and Plaxton, W. C.
(2000)
Eur. J. Biochem.
267,
4477-4485 |
10. | Plaxton, W. C. (1996) Annu. Rev. Plant Physiol. Plant Mol. Biol. 47, 185-214[CrossRef] |
11. | Plaxton, W. C. (1989) Eur. J. Biochem. 181, 443-451[Abstract] |
12. | Hattori, J., Baum, B. R., McHugh, S. G., Blakeley, S. D., Dennis, D. T., and Miki, B. L. (1995) Biochem. Sys. Ecol. 23, 773-780[CrossRef] |
13. | Knowles, V. L., Dennis, D. T., and Plaxton, W. C. (1989) FEBS Lett. 259, 130-132[CrossRef] |
14. | Plaxton, W. C., Dennis, D. T., and Knowles, V. L. (1990) Plant Physiol. 94, 1528-1534 |
15. |
Liaud, M-F.,
Lichtle, C.,
Apt, K.,
Martin, W.,
and Cerff, R.
(2000)
Mol. Biol. Evol.
17,
213-223 |
16. | Kaneko, T., Sato, S., Kotani, H., Tanaka, A., Asamizu, E., Nakamura, Y., Miyajima, N., Hirosawa, M., Sugiura, M., Sasamoto, S., Kimura, T., Hosouchi, T., Matsuno, A., Muraki, A., Nakazaki, N., Naruo, K., Okumura, S., Shimpo, S., Takeuchi, C., Wada, T., Watanabe, A., Yamada, M., Yasuda, M., and Tabata, S. (1996) DNA Res. 3, 109-136[Medline] [Order article via Infotrieve] |
17. | Golden, S. S., Natly, M. S., and Cho, D-Sc (1989) J. Bacteriol. 171, 24-29[Medline] [Order article via Infotrieve] |
18. | Guy, R. D., Vanlerberghe, G. C., and Turpin, D. H. (1989) Plant Physiol. 89, 1150-1157 |
19. | Allen, M. M. (1968) J. Phycol. 4, 1-4 |
20. | Bollag, D. M., Rozycki, M. D., and Edelstein, S. J. (1996) Protein Methods , 2nd Ed. , pp. 62-67, Wiley-Liss, New York |
21. | Brooks, S. P. G. (1992) BioTechniques 13, 906-911[Medline] [Order article via Infotrieve] |
22. | Dixon, M., and Webb, E. C. (1979) Enzymes , 3rd Ed , Academic Press Inc., New York |
23. | Brooks, S. P. G., and Storey, K. B. (1992) Anal. Biochem. 201, 119-126[Medline] [Order article via Infotrieve] |
24. |
Altshul, S. F.,
Madden, T. L.,
Schaffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402 |
25. | Falkner, G., Horner, F., Werdan, K., and Heldt, H. (1976) Plant Physiol. 58, 717-718 |
26. | Sakai, H., Suzuki, K., and Imahori, K. (1986) J. Biochem. (Tokyo) 99, 1157-1167[Abstract] |
27. | Chuang, D. T., and Utter, M. F. (1979) J. Biol. Chem. 254, 8434-8441[Medline] [Order article via Infotrieve] |
28. |
Schramm, A.,
Siebers, B.,
Tjaden, B.,
Brinkmann, H.,
and Hensel, R.
(2000)
J. Bacteriol.
182,
2001-2009 |
29. | Ireland, R. J., DeLuca, V., and Dennis, D. T. (1980) Plant Physiol. 65, 1188-1193 |
30. | Lin, M., Turpin, D. H., and Plaxton, W. C. (1989) Arch. Biochem. Biophys. 269, 219-227[Medline] [Order article via Infotrieve] |
31. | Pawluk, R., Scopes, R. K., and Griffiths-Smith, K. (1986) Biochem. J. 238, 275-281[Medline] [Order article via Infotrieve] |
32. | Mertens, E., Van Schaftingen, E. V., and Muller, M. (1992) Mol. Biochem. Parisitol. 54, 13-20[CrossRef][Medline] [Order article via Infotrieve] |
33. | Hnadelman, S. L., and Kreinces, G. H. (1973) J. Dent. Res. 52, 651-657[Medline] [Order article via Infotrieve] |
34. | Ihlenfeldt, M. J. A., and Gibson, J. (1975) Arch. Microbiol. 102, 13-21[Medline] [Order article via Infotrieve] |
35. | Biggins, J. (1969) J. Bacteriol. 99, 570-575[Medline] [Order article via Infotrieve] |